"Although absolute differences in readings were small, they can result in substantially higher rates of false negatives and ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. AARP’s Medicare experts share tips and updates to help manage ...

What just happened? Apple has been dealt a blow in its long-running patent battle against Masimo after a court ordered Cupertino to pay the health tech firm $634 million. The decision came on the same ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

In the latest chapter of the long-running legal war between Apple and medical tech company Masimo, a federal jury in California has ordered Apple to pay $634 million in damages. The jury found that ...

A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen-monitoring technology. Reuters reports the jury found ...

Nov 14 (Reuters) - A federal jury in California said on Friday that Apple (AAPL.O), opens new tab owes medical-monitoring technology company Masimo (MASI.O), opens new tab $634 million for infringing ...

Apple’s brush-up with Masimo a company that manufactures patient monitoring devices, over a patent lawsuit may not be over yet. 9to5Mac reports that, in new filings today, the ITC said it “has ...

Masimo, the medical technology company whose lawsuit led to the temporary sales pause of the Apple Watch Series 9 and Ultra 2, has sued the US Customs and Border Protection days after Apple released ...

Masimo is taking the U.S. government to court over its decision to allow blood oxygen tracking to return to the Apple Watch, saying its decision was unlawful and that Apple’s workaround still ...